National Multiple Sclerosis Society

Analysis

National Multiple Sclerosis Society is a registered charity in United States, based in New York, NY. It received its IRS tax-exemption ruling in October 1947, 79 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending September 2023, National Multiple Sclerosis Society reported income of $149.5m and spending of $172.9m, spending 116% of what it took in. Across the 5 years on record, from September 2019 to September 2023, income fell from $196.9m to $149.5m (-24%), an average of -6.7% a year. The sharpest change came in the year to September 2020, when income dropped by 21%. Over the whole period it spent 99% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, National Multiple Sclerosis Society sits at the 96th percentile: it is larger than about 96% of them. Against every charity in United States with reported income it ranks in the 99th percentile, and in the 99th percentile within NY. Charities of a similar size with the same main cause include Northeast Valley Health Corporation ($149.2m), Anna Jaques Hospital ($149.5m) and Newport Hospital ($149.0m).

On its Form 990 for the period ending September 2023, revenue came from contributions and grants 97% and program service revenue 0.0% of the total. Compensation of current officers, directors and key employees was $3.2m (1.8% of expenses). Other salaries and wages came to $65.5m. It paid $2.5m in professional fundraising fees. At year end it held assets of $184.2m against liabilities of $74.7m, net assets of $109.5m. It reported 968 employees.